View in EDS

A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer.
Authors: Yang Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China., Chang J; Fudan University Shanghai Cancer Center, Shanghai 200032, China., Huang C; Fujian Provincial Tumor Hospital, Fuzhou 350014, China., Zhang Y; Zhejiang Cancer Hospital, Hangzhou 310022, China., Wang J; Beijing Cancer Hospital, Beijing 100035, China., Shu Y; Jiangsu Provincial People's Hospital, Nanjing 210029, China., Burillon JP; Institut de Recherche Pierre Fabre, Boulogne, France., Riggi M; Institut de Recherche Pierre Fabre, Boulogne, France., Petain A; Institut de Recherche Pierre Fabre, Toulouse, France., Ferre P; Institut de Recherche Pierre Fabre, Toulouse, France., Liang Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China., Zhang L; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
Source: Journal of thoracic disease [J Thorac Dis] 2019 Aug; Vol. 11 (8), pp. 3347-3359.
Publication Type: Journal Article
Journal Info: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101533916 Publication Model: Print Cited Medium: Print ISSN: 2072-1439 (Print) Linking ISSN: 20721439 NLM ISO Abbreviation: J Thorac Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31559038
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.<br /><searchLink fieldCode="AU" term="%22Chang+J%22">Chang J</searchLink>; Fudan University Shanghai Cancer Center, Shanghai 200032, China.<br /><searchLink fieldCode="AU" term="%22Huang+C%22">Huang C</searchLink>; Fujian Provincial Tumor Hospital, Fuzhou 350014, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Zhejiang Cancer Hospital, Hangzhou 310022, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Beijing Cancer Hospital, Beijing 100035, China.<br /><searchLink fieldCode="AU" term="%22Shu+Y%22">Shu Y</searchLink>; Jiangsu Provincial People's Hospital, Nanjing 210029, China.<br /><searchLink fieldCode="AU" term="%22Burillon+JP%22">Burillon JP</searchLink>; Institut de Recherche Pierre Fabre, Boulogne, France.<br /><searchLink fieldCode="AU" term="%22Riggi+M%22">Riggi M</searchLink>; Institut de Recherche Pierre Fabre, Boulogne, France.<br /><searchLink fieldCode="AU" term="%22Petain+A%22">Petain A</searchLink>; Institut de Recherche Pierre Fabre, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Ferre+P%22">Ferre P</searchLink>; Institut de Recherche Pierre Fabre, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Liang+Y%22">Liang Y</searchLink>; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101533916%22">Journal of thoracic disease</searchLink> [J Thorac Dis] 2019 Aug; Vol. 11 (8), pp. 3347-3359.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AME+Publishing+Company%22">AME Publishing Company </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101533916 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>2072-1439 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220721439%22">20721439 </searchLink><i>NLM ISO Abbreviation: </i>J Thorac Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31559038
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.21037/jtd.2019.08.22
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3347
    Titles:
      – TitleFull: A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yang Y
      – PersonEntity:
          Name:
            NameFull: Chang J
      – PersonEntity:
          Name:
            NameFull: Huang C
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Shu Y
      – PersonEntity:
          Name:
            NameFull: Burillon JP
      – PersonEntity:
          Name:
            NameFull: Riggi M
      – PersonEntity:
          Name:
            NameFull: Petain A
      – PersonEntity:
          Name:
            NameFull: Ferre P
      – PersonEntity:
          Name:
            NameFull: Liang Y
      – PersonEntity:
          Name:
            NameFull: Zhang L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2019 Aug
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 2072-1439
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Journal of thoracic disease
              Type: main
ResultId 1